Zenotech Laboratories

Zenotech Laboratories EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is -18.97 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 161.03 M INR — a change of -111.78% (lower).

EBITDA

-18.97 MINR

YoY

-111.78%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zenotech Laboratories is 2026 -18.97 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zenotech Laboratories was 2025 161.03 M INR. It decreases by -111.78% lower compared to the previous year.

The Zenotech Laboratories EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-32.59 M INR
Jan 1, 2020
153.49 M INR
Jan 1, 2021
63.80 M INR
Jan 1, 2022
179.91 M INR
Jan 1, 2023
217.87 M INR
Jan 1, 2024
172.66 M INR
Jan 1, 2025
161.03 M INR
Jan 1, 2026
-18.97 M INR
The Zenotech Laboratories EBITDA history
YEAREBITDAYoY
-18.97 MINR-111.78%
161.03 MINR-6.73%
172.66 MINR-20.75%
217.87 MINR+21.10%
179.91 MINR+182.00%
63.80 MINR-58.43%
153.49 MINR-570.94%
-32.59 MINR-58.30%
-78.16 MINR-8.43%
-85.36 MINR+11.25%
-76.73 MINR-18.85%
-94.55 MINR-49.98%
-189.02 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zenotech Laboratories is -18.97 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Zenotech Laboratories changed from 161.03 M INR to -18.97 M INR, representing a -111.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories